In a patient with a percutaneous endoscopic gastrostomy (PEG) tube who is experiencing diarrhea, nausea, and weight loss while receiving metoclopramide and other prokinetic agents, how should the diarrhea be evaluated and managed?

Diarrhea in PEG Tube Patients: Evaluation and Management

First, immediately verify PEG tube position with imaging (CT or fluoroscopy) to rule out gastrocolocutaneous fistula or tube migration into the colon/duodenum, as these mechanical complications are critical causes of diarrhea that require urgent intervention.

Initial Evaluation: Rule Out Mechanical Complications

The most critical step is excluding tube malposition, which presents as a surgical emergency masquerading as feeding intolerance:

Red Flag: Gastrocolocutaneous Fistula

• Sudden onset diarrhea immediately after PEG feeding (within minutes) strongly suggests the tube has migrated through the colon 1
• Look for feculent drainage from the PEG tube site - this is pathognomonic 2, 3
• This complication can occur months after initial placement and even after routine tube exchanges 2, 4
• The tube may appear correctly positioned on endoscopy in the stomach, yet still traverse the colon 3, 5

Diagnostic Approach

1. Obtain abdominal CT with contrast - this is the gold standard for identifying tube malposition 4
2. If CT shows tube tip in duodenum or colon, this is your diagnosis
3. Fluoroscopy can demonstrate contrast filling the colon through the tube 1

Management of confirmed fistula:

• Remove the PEG tube immediately 1
• Endoscopic closure with hemoclips is effective 1
• Conservative management with nutritional support via nasogastric tube until fistula heals 2, 3
• Do NOT simply reposition - removal is required

If Tube Position is Confirmed Normal

Only after excluding mechanical complications should you evaluate other causes:

Assess for Small Intestinal Bacterial Overgrowth (SIBO)

• Common in patients with motility disorders already on prokinetics 6
• Trial sequential antibiotic therapy: metronidazole, amoxicillin-clavulanate, doxycycline, or norfloxacin 6
• Rifaximin is preferred for poorly absorbable coverage 6
• Consider alternating cycles to prevent resistance 6

Review Feeding Regimen

• Verify feeding rate is not too rapid
• Check osmolality of formula
• Ensure adequate tube flushing (40 mL water after feeds) 7

Medication Review

• Metoclopramide itself does not typically cause diarrhea per FDA labeling 8
• Review all other medications for diarrhea-inducing agents
• Consider if prokinetics are over-stimulating bowel motility

Common Pitfall to Avoid

The critical error is treating persistent diarrhea as "feeding intolerance" or infection without imaging the tube position. Multiple case reports document patients suffering weeks of intractable diarrhea, receiving unnecessary antibiotic treatment, when the actual problem was unrecognized tube malposition 5. The diarrhea in these cases is immediate (within minutes of feeding) and refractory to standard treatments 1.

Management Algorithm Summary

1. Day 1: Order abdominal CT if diarrhea is sudden-onset, occurs immediately with feeds, or is refractory
2. If fistula/malposition found: Remove tube, provide alternative nutrition, allow healing
3. If position normal: Trial antibiotics for SIBO (metronidazole or rifaximin first-line)
4. If SIBO treatment fails: Adjust feeding regimen (rate, formula osmolality)
5. Consider periodic antibiotic prophylaxis if SIBO recurs 6

The duodenal tube tip position, while controversial, has been documented to cause diarrhea that resolves with repositioning back to the stomach 4, so this should be corrected if identified.